Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data RETRACTABLE TECHNOLOGIES INC files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
29.8
34.5
33.3
41.8
81.9
188
94.8
43.6
33
38.3
Cost of revenue
19.5
24.5
23.1
27.7
44.9
93
66.6
34.5
34.1
38.2
Gross profit
10.3
9.97
10.2
14.1
37
95.4
28.3
9.11
-1.03
0.05
Research and development
0.57
0.74
0.62
0.52
0.57
0.9
0.53
0.58
0.67
0.68
Selling and marketing
4.03
4.66
4.4
4.22
4.06
4.48
4.54
5.71
5.85
6.82
General and administrative
8.8
8.35
6.79
6.43
8.3
17.4
24
14.3
13.6
12.8
Operating expenses
13.8
13.8
11.8
11.2
12.9
22.8
29.1
20.6
20.1
21.2
Operating income
-3.51
-3.78
-1.33
2.97
24.1
72.6
-0.85
-11.5
-21.1
-21.2
Interest expense
0.21
0.21
0.18
0.17
0.26
0.23
0.17
0.15
0.12
0.09
Interest income
0.03
0.07
0.15
0.35
2.26
Pre-tax income
-3.69
-3.92
-1.35
3.16
26.1
75
5.16
-8.92
-3.52
-12.3
Income tax
0
-0.19
-0.01
0.01
1.85
18.9
0.08
-1.91
8.37
0.29
Net income
-3.69
-3.74
-1.34
3.15
24.2
56.1
5.08
-7.01
-11.9
-12.6
EBITDA
-2.63
-2.94
-0.44
3.82
24.9
73.9
3.75
-3.96
-13.5
-13.4
EPS, basic
-0.15
-0.14
-0.06
0.07
0.80
1.65
0.15
-0.24
-0.40
-0.43
EPS, diluted
-0.15
-0.14
-0.06
0.07
0.80
1.63
0.15
-0.24
-0.40
-0.43
Shares, basic (weighted)
29.4
32
32.7
32.7
33.2
33.9
32.9
29.9
29.9
29.9
Shares, diluted (weighted)
29.4
32
32.7
32.7
33.3
34.2
33
29.9
29.9
29.9
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
16.2
14.9
9.65
5.93
17.6
29.2
19.7
12.7
4.24
2.59
Receivables
3.27
5.11
4.91
6.56
21.1
34.9
4.84
10.7
7.79
7.9
Inventory
7.02
6.21
7.55
7.45
10.2
20.6
20.7
17.6
19.2
17.2
Other current assets
0.19
0.42
0.64
0.64
0.68
0.7
1.27
0.95
0.75
0.71
Total current assets
26.7
26.6
25.8
28.4
69.5
105
88.8
77.6
73.3
63.1
Property, plant and equipment
12.1
11.4
10.9
10.6
30.8
87.9
100
93.5
87.3
79.2
Lease right-of-use assets
0.16
0.08
0.04
Total assets
38.8
38.2
37
39.2
105
206
196
180
161
143
Accounts payable
4.47
4.96
5.37
5.01
16.3
20.4
6.4
4.78
4.29
5.34
Accrued liabilities
0.54
0.55
0.54
0.61
0.83
1.06
1
0.87
1.07
0.76
Deferred revenue
2.34
0.44
0.2
0.38
0.35
Short-term debt
0.43
0.41
0.41
0.26
1.03
0.29
0.29
0.3
0.33
Total current liabilities
7.17
7.9
8.62
8.26
27.9
35.3
12.1
9.38
8.78
9.6
Long-term debt
3.5
3.08
2.64
2.38
2.71
1.81
1.53
1.23
0.9
Lease liabilities
0.08
Other non-current liabilities
0.08
0
24.5
70
75.5
69.8
63.9
58.1
Total liabilities
10.7
11
11.3
10.6
55.1
107
89.1
80.4
73.6
68.3
Total debt
3.93
3.49
3.05
2.64
3.74
2.1
1.82
1.54
1.23
0.9
Retained earnings
-32
-35.7
-37
-33.9
-9.67
41.2
46
38.8
26.7
13.9
Treasury stock
-5.27
-12.9
-12.9
-12.9
-12.9
Shareholders' equity
28.1
27.2
25.6
28.5
49.9
99.2
107
99.3
87.2
74.4
Total equity
28.1
27.2
25.6
28.5
49.9
99.2
107
99.3
87.2
74.4
Total liabilities and equity
38.8
38.2
37
39.2
105
206
196
180
161
143
Shares outstanding
29.7
32.7
32.7
32.7
34
33.5
29.9
29.9
29.9
29.9
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-3.69
-3.74
-1.34
3.15
24.2
56.1
5.08
-7.01
-11.9
-12.6
Depreciation and amortization
0.87
0.83
0.89
0.85
0.83
1.26
4.6
7.53
7.57
7.77
Stock-based compensation
0.39
0.67
0
0
0
3.66
10.1
0
0
Deferred income tax
-0.19
-4.63
-9.23
7.35
-1.87
8.39
Change in receivables
1.54
-1.86
0.15
-1.65
-14.6
-13.9
29.7
-6.46
2.31
-0.45
Change in inventory
-0.9
0.81
-1.04
0.09
-2.78
-10.4
-0.09
2.93
-1.61
-0.2
Change in payables
-1.23
0.49
0.41
-0.36
11.2
4.15
-14
-1.63
-0.49
1.05
Cash from operations
-0.79
-2.92
-1.2
2.19
19
32.8
16.8
2.77
-11.6
-7.06
Capital expenditures
-1.95
-0.09
-0.38
-0.63
-21
-58.4
-16.8
-0.85
-1.44
Purchases of investments
-2.99
-7.36
-2.24
-4.75
-18.1
-68.5
-0.9
-30.5
Sales and maturities of investments
2.71
3.97
0.08
3.76
58.6
6
37.1
Cash from investing
-1.95
-0.09
-3.37
-5.28
-19.3
-63
-31.2
-10.8
3.66
5.98
Debt issued
0.53
1.36
Debt repaid
-0.26
-0.44
-0.45
-0.41
-0.26
-0.27
-0.28
-0.28
-0.3
-0.34
Stock issued
0.86
2.35
0.92
5.3
0.01
Share buybacks
-5.27
-7.62
Cash from financing
0.9
1.69
-0.67
-0.63
12
41.8
4.99
0.94
-0.54
-0.57
Net change in cash
-1.85
-1.32
-5.23
-3.71
11.6
11.6
-9.44
-7.05
-8.43
-1.65
Free cash flow
-2.74
-3.01
-1.58
1.56
-2.05
-25.6
-0.06
1.91
-13
Interest paid
0.21
0.21
0.18
0.17
0.26
0.12
0.11
0.16
0.12
0.09
Income taxes paid
0
0
0
2.11
27.1
12.3
-9.75
-0.35
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.70 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
-1.4%
Gross profit / revenue.
Operating margin
-66.9%
Operating income / revenue.
EBITDA margin
-43.9%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-9.9%
Pre-tax income / revenue.
Net margin
-9.9%
Net income / revenue.
Operating cash flow margin
-14.6%
Cash from operations / revenue.
Return on equity (ROE)
-4.6%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-2.4%
Net income / average total assets.
Return on invested capital (ROIC)
-25.5%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
2.0%
Research and development expense / revenue.
D&A / revenue
23.0%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
15.8%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-26.1%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-14.1%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit CAGR, 3y
-88.1%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-73.6%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-14.7%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-11.3%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
8.3%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-11.3%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-10.0%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
6.3%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
0.0%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
-3.2%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
-2.1%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
4.93x
Current assets / current liabilities.
Quick ratio
0.87x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.20x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.11
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$1.13
Revenue / diluted weighted shares.
Operating cash flow per share
-$0.17
Cash from operations / diluted weighted shares.
Book value per share
$2.43
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.62x
Market cap / revenue.
P/B
0.29x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
0.29x
Market cap / tangible book value, when positive.
EV/Sales
0.54x
Enterprise value / revenue.
Earnings yield
-16.1%
Net income / market cap (the inverse of P/E).
What was RETRACTABLE TECHNOLOGIES INC's revenue in fiscal 2025?
RETRACTABLE TECHNOLOGIES INC reported revenue of $38.3M for fiscal 2025, 15.8% higher than the year before.
Was RETRACTABLE TECHNOLOGIES INC profitable in fiscal 2025?
No. It reported a net loss of $12.6M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.